RU2005114573A - METHOD FOR COUPLING ABSTINENT SYNDROME IN OPIEN DRUG PATIENTS - Google Patents

METHOD FOR COUPLING ABSTINENT SYNDROME IN OPIEN DRUG PATIENTS Download PDF

Info

Publication number
RU2005114573A
RU2005114573A RU2005114573/14A RU2005114573A RU2005114573A RU 2005114573 A RU2005114573 A RU 2005114573A RU 2005114573/14 A RU2005114573/14 A RU 2005114573/14A RU 2005114573 A RU2005114573 A RU 2005114573A RU 2005114573 A RU2005114573 A RU 2005114573A
Authority
RU
Russia
Prior art keywords
opien
coupling
drug patients
patients
drug
Prior art date
Application number
RU2005114573/14A
Other languages
Russian (ru)
Other versions
RU2290955C1 (en
Inventor
Евгений Евгеньевич Щерба (RU)
Евгений Евгеньевич Щерба
Original Assignee
Евгений Евгеньевич Щерба (RU)
Евгений Евгеньевич Щерба
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Евгений Евгеньевич Щерба (RU), Евгений Евгеньевич Щерба filed Critical Евгений Евгеньевич Щерба (RU)
Priority to RU2005114573/14A priority Critical patent/RU2290955C1/en
Publication of RU2005114573A publication Critical patent/RU2005114573A/en
Application granted granted Critical
Publication of RU2290955C1 publication Critical patent/RU2290955C1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

Способ купирования абстинентного синдрома у больных опийной наркоманией, включающий воздействие на его организм стрессорным фактором, отличающийся тем, что в качестве стрессорного фактора используют острую массивную кровопотерю в объеме от 10 до 20% от общего объема крови в зависимости от длительности употребления и суточной дозы наркотика.A method of relieving withdrawal symptoms in patients with opiate addiction, including exposure to his body as a stress factor, characterized in that acute massive blood loss in the amount of 10 to 20% of the total blood volume depending on the duration of use and the daily dose of the drug is used as a stress factor.
RU2005114573/14A 2005-05-13 2005-05-13 Method for interrupting abstinence syndrome in patients at opium narcomania RU2290955C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2005114573/14A RU2290955C1 (en) 2005-05-13 2005-05-13 Method for interrupting abstinence syndrome in patients at opium narcomania

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2005114573/14A RU2290955C1 (en) 2005-05-13 2005-05-13 Method for interrupting abstinence syndrome in patients at opium narcomania

Publications (2)

Publication Number Publication Date
RU2005114573A true RU2005114573A (en) 2006-11-20
RU2290955C1 RU2290955C1 (en) 2007-01-10

Family

ID=37501808

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005114573/14A RU2290955C1 (en) 2005-05-13 2005-05-13 Method for interrupting abstinence syndrome in patients at opium narcomania

Country Status (1)

Country Link
RU (1) RU2290955C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2444352C2 (en) * 2009-03-25 2012-03-10 Общество с ограниченной ответственностью "Лотос.мед" Method of treating alcoholic dependence and opium addiction 'universal psychopharmacological neurophysiological block'

Also Published As

Publication number Publication date
RU2290955C1 (en) 2007-01-10

Similar Documents

Publication Publication Date Title
DE60237199D1 (en) IMMEDIATE DELIVERY TO THE BODY OF A PATIENT
NZ597378A (en) Treatment of multiple sclerosis with laquinimod
IL175259A0 (en) Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof
RU2007122391A (en) S-MIRTAZAPINE FOR TIDAL TREATMENT
IL184697A (en) Injectable preparation containing diclofenic, a process for its preparation and use of the preparation in the manufacture of medication for the relief of pain and/or inflammation
RU2009101026A (en) APPLICATION OF THYMOSINE-ALPHA-1 FOR PRODUCING A MEDICINE FOR TREATING MALIGNANT MELANOMA IN STAGE IV
RU2005114573A (en) METHOD FOR COUPLING ABSTINENT SYNDROME IN OPIEN DRUG PATIENTS
SE0000698D0 (en) Use of a composition
RU2002103808A (en) METHOD FOR TREATING PAIN SYNDROME IN ONCOLOGIC PATIENTS
DK1675611T3 (en) Therapeutic uses for C-peptide
RU2006119263A (en) METHOD FOR TREATING PATIENTS WITH ROSATSEA
WO2004096141A3 (en) Method for promoting uninterrupted sleep by administration of trospium chloride
AR047154A1 (en) TREATMENT OF INSOMNIA IN HUMAN PATIENTS ADMINISTRANDOLES A DAILY AMOUNT OF GABOXADOL
WO2008079818A3 (en) Intravenous administration of water soluble analgesic formulations
Lindsay et al. How will the results of the HEMO study impact dialysis practice?
BR0316059A (en) Use of fosinopril to reduce cardiovascular events in dialysis patients
JP2005519919A5 (en)
Lee et al. Two case report on the patient with fibromyalgia syndrome (FMS) with Chuna and acupuncture
RU2004105675A (en) METHOD FOR COMPREHENSIVE TREATMENT OF CORNERAL ULCERS
CA2304899A1 (en) New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease
RU2004131190A (en) METHOD FOR PREVENTION AND TREATMENT OF POST-ISHEMIC DISORDERS IN ACUTE INJURY OF JOINTS
WO2009071725A3 (en) Use of valproate for the treatment of fear and phobia in subjects with alzheimer's disease
Bhatia et al. NICOTINE GUM DEPENDENCE
RU2007129578A (en) METHOD FOR INTEGRATED TREATMENT OF ACUTE-pointed URGENITAL TRACT
RU2004134447A (en) APPLICATION OF THE PRODUCT "MEXICOR" (2-Ethyl-6-methyl-3-hydroxypyridine succinate) for the treatment of nephritis and nephropathy

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20070514